- Home
- MYRG vs VRDN Comparison
MYRG vs VRDN Comparison
Compare MYRG & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MYRG | VRDN |
|---|---|---|
| Founded | 1891 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Sewer Pipeline Comm & Power Line Construction | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 2.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MYRG | VRDN |
|---|---|---|
| Price | $221.35 | $30.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | ★ $214.14 | $41.25 |
| AVG Volume (30 Days) | 230.3K | ★ 1.5M |
| Earning Date | 02-25-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 169.25 | N/A |
| EPS | ★ 6.17 | N/A |
| Revenue | ★ $3,514,140,000.00 | $70,789,000.00 |
| Revenue This Year | $8.62 | $26,257.62 |
| Revenue Next Year | $9.67 | $10.69 |
| P/E Ratio | $38.22 | ★ N/A |
| Revenue Growth | N/A | ★ 23340.07 |
| 52 Week Low | $97.72 | $9.90 |
| 52 Week High | $241.13 | $34.04 |
Technical Indicators
Market Signals| Indicator | MYRG | VRDN |
|---|---|---|
| Relative Strength Index (RSI) | 47.38 | 46.90 |
| Support Level | $220.76 | $28.96 |
| Resistance Level | $236.83 | $31.47 |
| Average True Range (ATR) | 8.03 | 1.06 |
| MACD | 0.47 | -0.37 |
| Stochastic Oscillator | 32.66 | 38.70 |
Price Performance
Historical ComparisonAbout MYRG MYR Group Inc.
MYR Group Inc is a U.S.-based holding company that provides specialty electrical construction services through its subsidiaries. The company operates through two segments. The transmission and distribution segment provides designing, engineering, procurement, construction, upgrade, maintenance, and repair services on transmission and distribution networks and substation facilities. The commercial and industrial segment provides services such as the design, installation, maintenance, and repair of commercial and industrial wiring, installation of traffic networks, and the installation of bridges. MYR Group generates the majority of its sales from the United States and Canada.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).